LNTH-2402

N/A

Report date: 2025/11/20 13:28:20
NME

Base Information

Drug NameLNTH-2402
Drug Alias Name177Lu-DOTA-RM2LNTH-2402
ClassificationRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Nuclides > Lutetium > 177LuRadiation-emitting products > Radionuclide Drug Conjugates +[4] 
Mechanisms of ActionGastrin releasing peptide receptor bindersIonising radiation emitters
TargetsGastrin releasing peptide receptor
Therapy Area/IndicationsSolid tumoursProstatic NeoplasmsLung Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLife Molecular Imaging Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLantheus Holdings IncLife Molecular Imaging Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursProstatic NeoplasmsLung Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A